Literature DB >> 18991020

Response of the ABCG2 promoter in T47D cells and BeWo cells to sex hormone treatment.

Satoru Yasuda1, Masaki Kobayashi, Shirou Itagaki, Takeshi Hirano, Ken Iseki.   

Abstract

The aim of this study was to elucidate the effects of sex hormones on activity of the ABCG2 promoter in different cell lines. T47D cells and BeWo cells were used as models for ABCG2-expressing cell lines, and luciferase assays using ABCG2 promoter-luciferase constructs were performed. It was shown that progesterone increased the response of the ABCG2 promoter in T47D cells but not in BeWo cells. On the other hand, estradiol had no effect on response of the ABCG2 promoter in either cell line. However, response of the ABCG2 promoter was enhanced by overexpression of ERalpha in both T47D cells and BeWo cells. T47D cells had higher sensitivity to ERalpha than did BeWo cells. Furthermore, it was shown that the inductive effect of progesterone on the ABCG2 promoter was inhibited by addition of RU486 or mithramycin A. Therefore, it was thought that the ABCG2 promoter responded to stimulation of the progesterone receptor (PR)-Sp1 pathway in T47D cells. Furthermore, progesterone suppressed the response of the ABCG2 promoter by changing the expression levels of PR-A and PR-B in BeWo cells. These findings suggested that there are differences between cell lines in the regulation mechanism of ABCG2 expression by sex hormone treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991020     DOI: 10.1007/s11033-008-9395-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  28 in total

1.  Regulation of tissue factor gene expression in human endometrium by transcription factors Sp1 and Sp3.

Authors:  G Krikun; F Schatz; N Mackman; S Guller; R Demopoulos; C J Lockwood
Journal:  Mol Endocrinol       Date:  2000-03

Review 2.  Expression and function of multidrug resistance transporters at the blood-brain barriers.

Authors:  Jean-Michel Scherrmann
Journal:  Expert Opin Drug Metab Toxicol       Date:  2005-08       Impact factor: 4.481

3.  Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells.

Authors:  A M Bamberger; C M Bamberger; B Gellersen; H M Schulte
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

4.  Estrogen receptor expression and growth-promoting function in human choriocarcinoma cells.

Authors:  S W Jiang; R V Lloyd; L Jin; N L Eberhardt
Journal:  DNA Cell Biol       Date:  1997-08       Impact factor: 3.311

5.  Expression level of ABCG2 in the placenta decreases from the mid stage to the end of gestation.

Authors:  Satoru Yasuda; Shirou Itagaki; Takeshi Hirano; Ken Iseki
Journal:  Biosci Biotechnol Biochem       Date:  2005-10       Impact factor: 2.043

6.  Cell- and ligand-specific regulation of promoters containing activator protein-1 and Sp1 sites by estrogen receptors alpha and beta.

Authors:  Jennifer R Schultz; Larry N Petz; Ann M Nardulli
Journal:  J Biol Chem       Date:  2004-10-26       Impact factor: 5.157

Review 7.  The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.

Authors:  Yehuda G Assaraf
Journal:  Drug Resist Updat       Date:  2006-11-07       Impact factor: 18.500

Review 8.  Efflux transporters of the human placenta.

Authors:  Amber M Young; Courtni E Allen; Kenneth L Audus
Journal:  Adv Drug Deliv Rev       Date:  2003-01-21       Impact factor: 15.470

Review 9.  Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).

Authors:  L Austin Doyle; Douglas D Ross
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

10.  Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells.

Authors:  Honggang Wang; Eun-Woo Lee; Lin Zhou; Peter C K Leung; Douglas D Ross; Jashvant D Unadkat; Qingcheng Mao
Journal:  Mol Pharmacol       Date:  2007-11-27       Impact factor: 4.436

View more
  6 in total

Review 1.  Transcription factor-mediated regulation of the BCRP/ABCG2 efflux transporter: a review across tissues and species.

Authors:  Ludwik Gorczyca; Lauren M Aleksunes
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-03-14       Impact factor: 4.481

2.  Rare Variants in the ABCG2 Promoter Modulate In Vivo Activity.

Authors:  Rachel J Eclov; Mee J Kim; Robin Smith; Nadav Ahituv; Deanna L Kroetz
Journal:  Drug Metab Dispos       Date:  2018-02-21       Impact factor: 3.922

Review 3.  Placental ABC Transporters: Biological Impact and Pharmaceutical Significance.

Authors:  Anand A Joshi; Soniya S Vaidya; Marie V St-Pierre; Andrei M Mikheev; Kelly E Desino; Abner N Nyandege; Kenneth L Audus; Jashvant D Unadkat; Phillip M Gerk
Journal:  Pharm Res       Date:  2016-09-19       Impact factor: 4.200

Review 4.  ATP-binding cassette efflux transporters in human placenta.

Authors:  Zhanglin Ni; Qingcheng Mao
Journal:  Curr Pharm Biotechnol       Date:  2011-04       Impact factor: 2.837

5.  ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma.

Authors:  R R Singh; K Kunkalla; C Qu; E Schlette; S S Neelapu; F Samaniego; F Vega
Journal:  Oncogene       Date:  2011-05-30       Impact factor: 9.867

6.  Low oxygen tension differentially regulates the expression of placental solute carriers and ABC transporters.

Authors:  Ludwik Gorczyca; Jianyao Du; Kristin M Bircsak; Xia Wen; Anna M Vetrano; Lauren M Aleksunes
Journal:  FEBS Lett       Date:  2020-10-07       Impact factor: 4.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.